What is Data Spectrum Corporation?
Founded in 1981, Data Spectrum Corporation has established itself as a cornerstone provider of molecular imaging phantoms. The company specializes in the development of high-fidelity tools for SPECT and PET imaging, which are essential for the rigorous acceptance testing and quality control protocols required by modern medical facilities. By ensuring that diagnostic equipment meets the stringent standards set by the American College of Radiology, Data Spectrum plays a critical role in the clinical accreditation process. Their commitment to domestic manufacturing and over four decades of technical expertise have made them a trusted partner for imaging professionals globally, bridging the gap between complex engineering and clinical diagnostic accuracy.
How much funding has Data Spectrum Corporation raised?
Data Spectrum Corporation has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Data Spectrum Corporation
PPP
Public-Private Partnership
What's next for Data Spectrum Corporation?
With this recent capital allocation, Data Spectrum Corporation is well-positioned to accelerate its research and development initiatives, particularly in the refinement of next-generation imaging phantoms that support emerging PET and SPECT technologies. The strategic focus will likely shift toward expanding their footprint in international markets while reinforcing their dominance in the domestic radiology sector. By leveraging this financial backing, the company aims to enhance its manufacturing capabilities and continue its legacy of providing innovative solutions that meet the evolving regulatory and technical demands of the medical imaging profession. The firm remains a vital link in the diagnostic supply chain, ensuring that healthcare providers can maintain the highest levels of equipment performance and patient safety.
See full Data Spectrum Corporation company page
